OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,000 | -41.1% | 20,138 | -2.9% | 0.00% | – |
| Q2 2023 | $107,000 | -4.5% | 20,738 | -1.6% | 0.00% | – |
| Q1 2023 | $112,000 | +89.8% | 21,068 | 0.0% | 0.00% | – |
| Q4 2022 | $59,000 | -34.4% | 21,068 | -3.2% | 0.00% | – |
| Q3 2022 | $90,000 | +3.4% | 21,768 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -19.4% | 21,768 | 0.0% | 0.00% | – |
| Q1 2022 | $108,000 | -19.4% | 21,768 | +13.0% | 0.00% | – |
| Q4 2021 | $134,000 | +4.7% | 19,268 | +50.9% | 0.00% | – |
| Q3 2021 | $128,000 | -12.3% | 12,768 | +24.3% | 0.00% | – |
| Q2 2021 | $146,000 | -21.1% | 10,268 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $185,000 | -29.1% | 11,284 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $261,000 | -67.0% | 12,660 | -86.8% | 0.00% | -75.0% |
| Q2 2020 | $790,000 | – | 95,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |